MCRcI® Stem Cell Treatment for Diffuse Coronary Artery Disease

NCT04052191 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease

Interventions

BIOLOGICAL: MCRcI® stem cells

Sponsor

Honya Medical Inc

Collaborators

[object Object]